[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513576":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":33,"responsibleParty":50,"collaborators":18,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":18,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":18,"enrollmentInfo":61,"targetDuration":18,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":18,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CirrhosisRx","EXPERIMENTAL","Providers in this arm will have access to the CirrhosisRx CDS system, which aggregates and organizes clinical data, presents them in clinically relevant\u002Fintuitive fashion for cirrhosis care, and linked to order sets consistent with national guidelines.",[13],"Other: CirrhosisRx CDS",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","NO_INTERVENTION","Providers in this arm will not have access to the CirrhosisRx CDS system.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"CirrhosisRx CDS","CirrhosisRx is a cirrhosis-specific CDS that organizes clinical data into clinically relevant groupings and links them to order sets consistent with national practice guidelines for inpatient cirrhosis care.",[9],[25],{"name":26,"affiliation":5,"role":27},"Jin Ge, MD, MBA","PRINCIPAL_INVESTIGATOR",[29],{"name":26,"role":30,"phone":31,"phoneExt":18,"email":32},"CONTACT","415-502-8070","jin.ge@ucsf.edu",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University of California San Francisco Medical Center","RECRUITING","San Francisco","California","94143","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-122.41942,37.77493,{"lat":46,"lon":45},[49],{"name":26,"role":30,"phone":31,"phoneExt":18,"email":32},{"type":51,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100513576","cirrhosisrx-cds-system-100513576",false,"NCT05967273","CirrhosisRx CDS System","Pragmatic Randomized Controlled Trial to Evaluate the Effect of CirrhosisRx, a Novel Clinical Decision Support System, on Guideline-adherence and Clinical Outcomes for Patients With Cirrhosis","Inclusion Criteria:\n\n* All adult (age ≥ 18 years) patients who have cirrhosis identified based on 1+ chronic liver disease and 1+ cirrhosis (or its complications) International Classification of Diseases, Revision 10 diagnosis codes OR mention of cirrhosis or portal hypertension (or their complications) in clinical documentation admitted at our institution.\n\nExclusion Criteria:\n\n* Children (age \\\u003C 18 years)\n* patients who do not meet the cirrhosis definition criteria as noted above\n* ambulatory patients","ALL","18 Years",{"count":62,"type":63},2106,"ESTIMATED","INTERVENTIONAL",[66],"NA","The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus \"usual care\" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.",[69,70],"Cirrhosis","Decision Support Systems, Clinical","2026-03-26",{"date":73,"type":74},"2026-04-01","ACTUAL",{"date":76,"type":74},"2025-01-14",{"date":78,"type":63},"2027-01",{"name":5,"class":6},1]